Table 1 Baseline characteristics for Mitra Plus women on ART for life
Characteristic | All women (n = 84) | Analyzed women (n = 73) |
|---|---|---|
Age in years, median (IQR)* | 29 (25–32) | 29 (25–33) |
Education years, median | 7 | 7 |
Gravidity, median (IQR) | 2 (1–3) | 2 (2–3) |
Parity, median (IQR) | 1 (0–2) | 1 (0–2) |
Hemoglobin median (IQR) | 9.9 (8.6-10.9) | 9.9 (8.6-10.8) |
CD4 count (cell/μL) at enrolment, median(IQR) | 139 (95–173) | 139 (98–174) |
CD4 % at enrolment, median (IQR) | 10 (6–13) | 11 (6–13) |
Viral load, median (IQR) | 66,648 (15,253-193,182) | 66,569 (15,051-195,289) |
10 log Viral load mean | 10.77 | 10.73 |
Karnofsky score, median (IQR) | 92 (90–98) | 92 (90–100) |
WHO clinical stage at enrolment | ||
Stage 1 | 64/84 (76%) | 55/73 (76%) |
Stage 2 | 10/84 (12%) | 9/73 (12%) |
Stage 3 | 1/84 (1%) | 1/73 (1%) |
Stage 4 | 9/84 (11%) | 8/73 (11%) |
Marital status | ||
Married | 44/84 (52%) | 40/73 (55%) |
Cohabiting | 31/84 (37%) | 26/73 (35%) |
Not married | 9/84 (11%) | 7/73 (10%) |
Disclosed HIV status to partner/relative | ||
No | 69/83 (71%) | 54/72 (75%) |
Yes | 24/83 (29%) | 18/72 (25%) |
Partner’s HIV status | ||
Negative | 10/76 (13%) | 10/66 (15%) |
Positive | 5/76 (7%) | 5/66 (8%) |
Not known | 61/76 (80%) | 51/66 (77%) |